Newsfiscal.ai
Caribou Biosciences Announces Acceptance of Clinical Abstracts for 2026 ASH Annual Meeting
· Published
Article summary
Caribou Biosciences announced that clinical abstracts for its vispa-cel and CB-011 programs have been accepted for presentation at the 2026 American Society of Hematology (ASH) Annual Meeting.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…